Adopting the Evolving Management of HR+/HER2-mBC into Practice Podcast Por Annenberg Center for Health Sciences arte de portada

Adopting the Evolving Management of HR+/HER2-mBC into Practice

Adopting the Evolving Management of HR+/HER2-mBC into Practice

De: Annenberg Center for Health Sciences
Escúchala gratis

Acerca de esta escucha

 Survival outcomes for patients with HR+/HER2- mBC remain suboptimal, despite first-line treatment strategies with endocrine therapy (ET). Greater understanding of the biology of HR+/HER2- mBC, including the role of biomarkers like ESR1 mutations, and the development of biopsy techniques for early mutation detection, have paved the way for personalized treatment approaches. In this activity, medical oncologists discuss integrating these evidence-based advancements into practice.Annenberg Center for Health Sciences Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Navigating Through the Current Treatment of Patients with HR+/HER2- mBC

    Navigating Through the Current Treatment of Patients with HR+/HER2- mBC
    Apr 9 2025

    Navigating Through the Current Treatment of Patients with HR+/HER2- mBC
    Más Menos
    7 m
  • Molecular and Tumor Profiling

    Molecular and Tumor Profiling
    Apr 9 2025

    Molecular and Tumor Profiling
    Más Menos
    23 m
Todavía no hay opiniones